Back to Search
Start Over
Vitiligo under anti–programmed cell death-1 therapy is associated with increased survival in melanoma patients
- Source :
- Journal of The American Academy of Dermatology, Journal of The American Academy of Dermatology, Elsevier, 2020, 82 (3), pp.770-772. ⟨10.1016/j.jaad.2019.11.017⟩
- Publication Year :
- 2020
- Publisher :
- HAL CCSD, 2020.
-
Abstract
- International audience
- Subjects :
- Adult
Male
Skin Neoplasms
Programmed Cell Death 1 Receptor
Vitiligo
Dermatology
Antibodies, Monoclonal, Humanized
030207 dermatology & venereal diseases
03 medical and health sciences
0302 clinical medicine
Antineoplastic Agents, Immunological
Programmed cell death 1
medicine
Humans
Melanoma
ComputingMilieux_MISCELLANEOUS
Aged
Retrospective Studies
Aged, 80 and over
biology
business.industry
Middle Aged
medicine.disease
3. Good health
Survival Rate
Nivolumab
030220 oncology & carcinogenesis
biology.protein
Cancer research
Female
Drug Eruptions
business
[SDV.MHEP]Life Sciences [q-bio]/Human health and pathology
Subjects
Details
- Language :
- English
- ISSN :
- 01909622 and 10976787
- Database :
- OpenAIRE
- Journal :
- Journal of The American Academy of Dermatology, Journal of The American Academy of Dermatology, Elsevier, 2020, 82 (3), pp.770-772. ⟨10.1016/j.jaad.2019.11.017⟩
- Accession number :
- edsair.doi.dedup.....d054e20ec5d489e7775983a14ec4ae33